Literature DB >> 22213140

Odontogenic ameloblasts-associated protein (ODAM), via phosphorylation by bone morphogenetic protein receptor type IB (BMPR-IB), is implicated in ameloblast differentiation.

Hye-Kyung Lee1, Jong-Tae Park, Young-Sik Cho, Hyun-Sook Bae, Moon-Il Cho, Joo-Cheol Park.   

Abstract

To elucidate the function of the odontogenic ameloblast-associated protein (ODAM) in ameloblasts, we identified more than 74 proteins that interact with ODAM using protoarray. Of the identified proteins, bone morphogenetic protein receptor type-IB (BMPR-IB) was physiologically relevant in differentiating ameloblasts. ODAM and BMPR-IB exhibited similar patterns of expression in vitro, during ameloblast differentiation. ODAM and BMPR-IB interacted through the C-terminus of ODAM, which resulted in increased ODAM phosphorylation in the presence of bone morphogenetic protein 2 (BMP-2). Immunoprecipitation assays using Ser-Xaa-Glu (SXE) mutants of ODAM demonstrated that the phosphorylation of ODAM by BMPR-IB occurs at this motif, and this phosphorylation is required for the activation of MAPKs. ODAM phosphorylation was detected in ameloblasts during ameloblast differentiation and enamel mineralization in vitro and involved in the activation of downstream factors of MAPKs. Therefore, the BMP-2-BMPR-IB-ODAM-MAPK signaling cascade has important roles in ameloblast differentiation and enamel mineralization. Our data suggest that ODAM facilitates the progression of tooth development in cooperation with BMPR-IB through distinct domains of ODAM.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213140     DOI: 10.1002/jcb.24047

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  An inductive signalling network regulates mammalian tooth morphogenesis with implications for tooth regeneration.

Authors:  Z Li; M Yu; W Tian
Journal:  Cell Prolif       Date:  2013-08-17       Impact factor: 6.831

2.  ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer.

Authors:  Yun Luo; Jie-Ying Wu; Guo-Liang Hou; Min-Hua Lu; Zhi Shi; Jin-Ming Di
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Odontoblastic inductive potential of epithelial cells derived from human deciduous dental pulp.

Authors:  Hye-Kyung Lee; Ji-Won Park; You-Mi Seo; Ha Hoon Kim; Gene Lee; Hyun-Sook Bae; Joo-Cheol Park
Journal:  J Mol Histol       Date:  2016-04-20       Impact factor: 2.611

Review 4.  BMP Signaling Pathway in Dentin Development and Diseases.

Authors:  Mengmeng Liu; Graham Goldman; Mary MacDougall; Shuo Chen
Journal:  Cells       Date:  2022-07-16       Impact factor: 7.666

Review 5.  The versatile roles of odontogenic ameloblast-associated protein in odontogenesis, junctional epithelium regeneration and periodontal disease.

Authors:  Sipin Zhu; Chuan Xiang; Oscar Charlesworth; Samuel Bennett; Sijuan Zhang; Maio Zhou; Omar Kujan; Jiake Xu
Journal:  Front Physiol       Date:  2022-09-02       Impact factor: 4.755

6.  Odontogenic Ameloblast-associated Protein (ODAM) Mediates Junctional Epithelium Attachment to Teeth via Integrin-ODAM-Rho Guanine Nucleotide Exchange Factor 5 (ARHGEF5)-RhoA Signaling.

Authors:  Hye-Kyung Lee; Suk Ji; Su-Jin Park; Han-Wool Choung; Youngnim Choi; Hyo-Jung Lee; Shin-Young Park; Joo-Cheol Park
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 7.  Maturation and beyond: proteins in the developmental continuum from enamel epithelium to junctional epithelium.

Authors:  Bernhard Ganss; Nastaran Abbarin
Journal:  Front Physiol       Date:  2014-09-25       Impact factor: 4.566

8.  Mutant GDF5 enhances ameloblast differentiation via accelerated BMP2-induced Smad1/5/8 phosphorylation.

Authors:  Jia Liu; Kan Saito; Yuriko Maruya; Takashi Nakamura; Aya Yamada; Emiko Fukumoto; Momoko Ishikawa; Tsutomu Iwamoto; Kanako Miyazaki; Keigo Yoshizaki; Lihong Ge; Satoshi Fukumoto
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.